MD2286C2 - Immunoreagent for microbial toxigenicity indication - Google Patents

Immunoreagent for microbial toxigenicity indication

Info

Publication number
MD2286C2
MD2286C2 MDA20010039A MD20010039A MD2286C2 MD 2286 C2 MD2286 C2 MD 2286C2 MD A20010039 A MDA20010039 A MD A20010039A MD 20010039 A MD20010039 A MD 20010039A MD 2286 C2 MD2286 C2 MD 2286C2
Authority
MD
Moldova
Prior art keywords
toxigenicity
microbial
indication
immunoreagent
chlamydospores
Prior art date
Application number
MDA20010039A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD20010039A (en
MD2286B2 (en
Inventor
Тудор ГЕОРГИЦА
Рита АНГЕЛ
Николае ПУШКАШ
Лилиана КИРИЛЭ
Original Assignee
Тудор ГЕОРГИЦА
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тудор ГЕОРГИЦА filed Critical Тудор ГЕОРГИЦА
Priority to MDA20010039A priority Critical patent/MD2286C2/en
Publication of MD20010039A publication Critical patent/MD20010039A/en
Publication of MD2286B2 publication Critical patent/MD2286B2/en
Publication of MD2286C2 publication Critical patent/MD2286C2/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to microbiology and may be used for rapid indication of microbial toxigenicity.The immunoreagent includes antitoxic immune serum, chlamydospores of Ustilago maydis and 0,01% sodium merthiolate solution, in the following ratio of ingredients, % vol.:The result of the invention consists in accelerating the microbial toxigenicity indication, enhancing the reagent's sensibility and specificity, as well as increasing the storage life thereof.
MDA20010039A 2001-02-14 2001-02-14 Immunoreagent for microbial toxigenicity indication MD2286C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010039A MD2286C2 (en) 2001-02-14 2001-02-14 Immunoreagent for microbial toxigenicity indication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010039A MD2286C2 (en) 2001-02-14 2001-02-14 Immunoreagent for microbial toxigenicity indication

Publications (3)

Publication Number Publication Date
MD20010039A MD20010039A (en) 2002-08-31
MD2286B2 MD2286B2 (en) 2003-10-31
MD2286C2 true MD2286C2 (en) 2004-06-30

Family

ID=19739753

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010039A MD2286C2 (en) 2001-02-14 2001-02-14 Immunoreagent for microbial toxigenicity indication

Country Status (1)

Country Link
MD (1) MD2286C2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723794A (en) * 1993-07-02 1995-01-27 Nippon Sanso Kk Culture medium for identifying bacterium and method for identifying bacterium
WO2002020829A1 (en) * 2000-09-07 2002-03-14 Centro Nacional De Biopreparados Culture medium and method for identifying gram-negative microorganisms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723794A (en) * 1993-07-02 1995-01-27 Nippon Sanso Kk Culture medium for identifying bacterium and method for identifying bacterium
WO2002020829A1 (en) * 2000-09-07 2002-03-14 Centro Nacional De Biopreparados Culture medium and method for identifying gram-negative microorganisms

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Справочник по микробиологическим и вирусологическим методам исследования, под редакцией Биргера М.О. М., Медицина, 1982, с. 239 – 241 *
Справочник по микробиологическим и вирусологическим методам исследования, под редакцией М.О. БИРГЕРА, Москва, *

Also Published As

Publication number Publication date
MD20010039A (en) 2002-08-31
MD2286B2 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
PT1157041E (en) ANTIBODIES FOR CANCER THERAPY AND DIAGNOSIS
DE60113381D1 (en) AUTOMATION IN PROTEIN DICE BY PROTEIN LIBRARIES
DE60144145D1 (en) Subtilisin variant
EP1071827A4 (en) Mixed cell diagnostic systems
HK1033582A1 (en) Antibodies to death receptor 4 (dr4) and uses thereof
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
MY131964A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
AU5965301A (en) Mixed cell diagnostic systems
NZ334518A (en) Homocysteine desulphurase from the protozoan trichomonas vaginalis
Mishima et al. Arginine-specific ADP-ribosyltransferase and its acceptor protein p33 in chicken polymorphonuclear cells: co-localization in the cell granules, partial characterization, and in situ mono (ADP-ribosyl) ation
DiSCIPIO The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase
CA2366514A1 (en) Diagnostic and therapeutic use of antibodies against the urokinase receptor
HUP9901464A2 (en) Process for selection of bacterium strains
DE60132443D1 (en) IN LIVING TARGET CELLS
TR200101493T2 (en) Eletriptan hydrobromide monohydrate
DE60208777D1 (en) LIQUID DETERGENTS WITH IMPROVED ALPHA AMYLASE ENZYME STABILITY
MD2286C2 (en) Immunoreagent for microbial toxigenicity indication
MXPA03004539A (en) Isolated luciferases and the use thereof.
EP1356076A4 (en) Methods and compositions for extracting proteins from cells
WO2001053352A3 (en) Sperm specific proteins
EP0363106A3 (en) Use of cationic surfactant to extract the chlamydial major outer membrane protein antigen
WO2004078783A3 (en) Enzymes involved in apoptosis
RU2010136820A (en) NEW FER-TYPE PROTEIN CONTAINING ITS PHARMACEUTICAL COMPOSITION AND METHOD OF ITS USE
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU7139501A (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees